Fanconi anemia (FA) is a rare genetic disorder impairing bone marrow's blood cell production, leading to severe health issues ...

The Randolph Central School community recently came together for the 12th annual Cards Against Cancer – raising $18,712 for ...

Bone-marrow specimens were obtained by aspiration ... The limitation of these findings to Fanconi's aplastic anemia provides a useful diagnostic tool for this disease and may serve to classify ...

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...

Sigma Planning Corp lessened its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 6.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 23,375 ...

Rocket’s lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure (BMF ...

The bone marrow was quickly recognized as the most ... the first cord blood transplant was successfully performed for a child with Fanconi's anemia, [2] an event that led to the ultimate ...

Bone Marrow Failure Syndromes (BMFS ... generally occur in pediatric populations and are initiated by somatic genetic mutations (e.g. Fanconi Anemia, Dyskeratosis Congenital and Shwachman-Diamond ...